Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs

被引:282
作者
Hu, JH
Johnston, KP
Williams, RO
机构
[1] Univ Texas, Coll Pharm, Div Pharmaceut, Austin, TX 78712 USA
[2] Univ Texas, Coll Pharm, Dept Chem Engn, Austin, TX 78712 USA
[3] Forest Labs Inc, Pharmaceut Res & Dev, Inwood, NY USA
关键词
nanoparticle engineering process; poorly water soluble drug; water insoluble drug; nanoparticle; solubility; dissolution; bioavailability; drug delivery; particle engineering; wet milling; high pressure homogenization; PCA; SEDS; SAS; RESAS; SFL; EPAS;
D O I
10.1081/DDC-120030422
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Poor water solubility is an industry wide issue, especially for pharmaceutical scientists in drug discovery and drug development. In recent years, nanoparticle engineering processes have become promising approaches for the enhancement of dissolution rates of poorly water soluble drugs. Nanoparticle engineering enables manufacturing of poorly water soluble drugs into nanoparticles alone, or incorporation with a combination of pharmaceutical excipients. The use of these processes has dramatically improved in vitro dissolution rates and in vivo bioavailabilities of many poorly water soluble drugs. This review highlights several commercially or potentially commercially available nanoparticle engineering processes recently reported in the literature for increasing the dissolution properties of poorly water soluble drugs.
引用
收藏
页码:233 / 245
页数:13
相关论文
共 74 条
[1]  
Adams T.H, 1982, US Patent, Patent No. [4323478, 4,323,478]
[2]  
Adams T.H., 1980, US Patent No, Patent No. [4,211,015, 4211015, 4211015 A]
[3]  
[Anonymous], [No title captured]
[4]  
[Anonymous], [No title captured]
[5]   POLYMERIC MICROSPHERES PREPARED BY SPRAYING INTO COMPRESSED CARBON-DIOXIDE [J].
BODMEIER, R ;
WANG, H ;
DIXON, DJ ;
MAWSON, S ;
JOHNSTON, KP .
PHARMACEUTICAL RESEARCH, 1995, 12 (08) :1211-1217
[6]   Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[7]  
Briggs A.L, 1976, US Patent No, Patent No. [3932943, 3,932,943]
[8]  
Briggs A.L., 1973, US Patent No, Patent No. [3,721,725, 3721725]
[9]  
Briggs A.L., 1975, US Patent No, Patent No. [3,928,566, 3928566]
[10]  
Buxton IR, 1984, US Patent, Patent No. [4,470,202, 4470202]